Congenital Tuberculosis

Abstract

Tuberculosis (TB) is a global public health problem with WHO South-East Asia Region accounting for about 45% of total cases. Tuberculosis is the ninth leading cause of death worldwide and is the leading infectious cause, ranking above HIV/AIDS. In 2016, about 1.3 million HIV negative people died due to tuberculosis [1]. However, Congenital Tuberculosis (CTB) is extremely rare condition with only less than 400 cases being reported thus far [2,3]. As the diagnosis and thus the treatment are often delayed, it has a mortality rate of almost 50% and about 22% in even those who receive treatment [4].